Tuesday, Citi analysts maintained a Neutral rating on Medtronic , Inc. (NYSE:MDT) shares, a prominent healthcare equipment player with a $104.88 billion market cap and $33 billion in annual revenue, ...
Investing.com -- Shares of Medtronic plc (NYSE:MDT) climbed 3% after the company announced that the Centers for Medicare & Medicaid Services (CMS) has initiated a national coverage analysis (NCA) for ...
Investing.com -- Shares of Medtronic plc (NYSE:MDT) climbed 3% after the company announced that the Centers for Medicare & Medicaid Services (CMS) has initiated a national coverage analysis (NCA ...
Tuesday, Citi analysts maintained a Neutral rating on Medtronic , Inc. (NYSE:MDT) shares, a prominent healthcare equipment player with a $104.88 billion market cap and $33 billion in annual ...
The Medtronic-Contego deal includes the recently FDA-approved Neuroguard IEP 3-in-1 carotid stenting system. Neuroguard IEP delivers a high-performance stent, post-dilation balloon and an ...
Contego’s portfolio includes the Neuroguard carotid stent system and Excipio ... The agreement with Contego follows Medtronic’s announcement last week of an exclusive five-year deal to sell Kuros ...
January 13, 2025—Gore & Associates announced the recent CE Mark approval of a lower-profile Gore Viabahn VBX balloon expandable endoprosthesis (VBX stent graft). The lower-profile device will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback